Related references
Note: Only part of the references are listed.Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation
Ioannis E. Michailidis et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2011)
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
Birgit Schoeberl et al.
CANCER RESEARCH (2010)
EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors
Kenji Takeuchi et al.
FEBS JOURNAL (2010)
Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
Gur Pines et al.
FEBS LETTERS (2010)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Deric L. Wheeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047
Seiji Adachi et al.
CANCER LETTERS (2009)
Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
Natalia Jura et al.
CELL (2009)
The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding
Jennifer L. Macdonald-Obermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Monica Red Brewer et al.
MOLECULAR CELL (2009)
EGFR family: Structure physiology signalling and therapeutic targets
Antony W. Burgess
GROWTH FACTORS (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation
Kristina W. Thiel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines
D. W. Rusnak et al.
CELL PROLIFERATION (2007)
Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis
James C. Garbe et al.
CELL CYCLE (2007)
Structure of the membrane reconstituted transmembrane-juxtamembrane peptide EGFR(622-660) and its interaction with Ca2+/calmodulin
Takeshi Sato et al.
BIOCHEMISTRY (2006)
p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy
Yaara Zwang et al.
EMBO JOURNAL (2006)
Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue
Karl-Ludwig Schaefer et al.
NEOPLASIA (2006)
Targeting the EGFR pathway for cancer therapy
James B. Johnston et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Apoptosis signal-regulating kinase 1 is involved not only in apoptosis but also in non-apoptotic cardiomyocyte death
T Watanabe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family
S McLaughlin et al.
JOURNAL OF GENERAL PHYSIOLOGY (2005)
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells
MR Verneris et al.
CLINICAL CANCER RESEARCH (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A basic peptide within the juxtamembrane region is required for EGF receptor dimerization
S Aifa et al.
EXPERIMENTAL CELL RESEARCH (2005)
Transmembrane peptides as inhibitors of ErbB receptor signaling
A Bennasroune et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Antennapedia and HIV transactivator of transcription (TAT) protein transduction domains promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans
S Console et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human epithelial cell immortalization as a step in carcinogenesis
MR Stampfer et al.
CANCER LETTERS (2003)
Share Paper
